Ed Miner, MD, FACC
Utah, Chapter President
ACC Governor, Utah

Rockies Chapter Meeting Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit: ACC Rockies Chapter Meeting 2025

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • Use of HEPA Purifiers at Home Can Significantly Reduce SBP
    Using portable high-efficiency particulate air (HEPA) purifiers at home can significantly lower systolic blood pressure (SBP) in adults with elevated baseline readings, even in areas with relatively low overall air pollution levels, according to a study published Aug. 6 in JACC.
  • New Concise Clinical Guidance Addresses Evaluation and Management of Pericarditis
    The ACC’s newest Concise Clinical Guidance (CCG) expert consensus statement focuses on diagnostic and therapeutic advances in evaluating and managing pericarditis, with the goal of helping to close the educational gaps surrounding this condition for providers, payers and patients.
  • Low SGLT2i Use Among Patients With HF in the Ambulatory Setting | NCDR Study
    The majority of ambulatory patients with heart failure (HF) eligible for SGLT2 inhibitor therapy did not receive it, despite increasing rates of SGLT2 inhibitor use in this patient population and high variability across sites, according to a study recently published in JAMA Cardiology.
  • A Dynamic Model to Estimate Bleeding Risk Post PCI | NCDR Study
    A dynamic model to estimate risk of major bleeding after PCI, trained and validated using data from the ACC's CathPCI Registry, exhibited less predictive error than static risk prediction models, according to a recent study published in PLOS Digital Health.
  • Kidney Function Decline May Precede HF Event by up to 1 Year in HFrEF Patients
    In patients with heart failure with reduced ejection fraction (HFrEF), kidney function decline may accelerate up to one year before a HF hospitalization or HF death, linking to symptomatic congestion, according to data from two clinical trials and a real-world study published July 30 in the European Heart Journal.